Pharmacological targeting of mitochondrial complex I deficiency: the cellular level and beyond.

[1]  R. Garesse,et al.  Animal models of mitochondrial DNA transactions in disease and ageing , 2010, Experimental Gerontology.

[2]  C. Hunte,et al.  Functional Modules and Structural Basis of Conformational Coupling in Mitochondrial Complex I , 2010, Science.

[3]  S. Hersh.  Mitochondria: An Emerging Target for Therapeutics , 2010, Clinical pharmacology and therapeutics.

[4]  Sion L. Williams,et al.  Emerging therapeutic approaches to mitochondrial diseases. , 2010, Developmental disabilities research reviews.

[5]  J. Smeitink,et al.  Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells. , 2010, Biochimica et biophysica acta.

[6]  Y. Al-sheikh,et al.  The effect of aging and increasing ascorbate concentrations on respiratory chain activity in cultured human fibroblasts , 2010, Cell biochemistry and function.

[7]  R. Rodenburg,et al.  Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level. , 2010, Developmental disabilities research reviews.

[8]  R. Palmiter,et al.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome , 2010, Proceedings of the National Academy of Sciences.

[9]  Cindy E J Dieteren,et al.  Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. , 2010, Antioxidants & redox signaling.

[10]  S. Moncada.  Mitochondria as pharmacological targets , 2010, British journal of pharmacology.

[11]  P. Bénit,et al.  Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development. , 2010, Trends in molecular medicine.

[12]  Rouslan G. Efremov,et al.  The architecture of respiratory complex I , 2010, Nature.

[13]  J. Finsterer,et al.  Drugs interfering with mitochondrial disorders , 2010, Drug and chemical toxicology.

[14]  P. Kador,et al.  Multifunctional antioxidants for the treatment of age-related diseases. , 2010, Journal of medicinal chemistry.

[15]  Ana Navarro,et al.  Frontiers in Aging Neuroscience Aging Neuroscience Mammalian Aging and Brain Mitochondrial Impairment in Aging and Neurodegenerative Diseases Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease , 2022 .

[16]  D. Wallace,et al.  Mitochondrial energetics and therapeutics. , 2010, Annual review of pathology.

[17]  D. Rubinsztein,et al.  Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. , 2010, Free radical biology & medicine.

[18]  J. Smeitink,et al.  Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency , 2011, Journal of Inherited Metabolic Disease.

[19]  J. Esseling,et al.  Calcium and ATP handling in human NADH:ubiquinone oxidoreductase deficiency. , 2009, Biochimica et biophysica acta.

[20]  T. Wenz.  PGC‐1α activation as a therapeutic approach in mitochondrial disease , 2009, IUBMB life.

[21]  Z. Ungvari,et al.  Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells , 2009, American journal of physiology. Heart and circulatory physiology.

[22]  J. Smeitink,et al.  Mitochondrial dynamics in human NADH:ubiquinone oxidoreductase deficiency. , 2009, The international journal of biochemistry & cell biology.

[23]  I. Cho,et al.  Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3β Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway , 2009, Molecular Pharmacology.

[24]  D. Wallace,et al.  The pathophysiology of mitochondrial disease as modeled in the mouse. , 2009, Genes & development.

[25]  Z. Ungvari,et al.  Resveratrol induces mitochondrial biogenesis in endothelial cells , 2009, American journal of physiology. Heart and circulatory physiology.

[26]  C. Pinkert,et al.  NDUFS4: creation of a mouse model mimicking a Complex I disorder. , 2009, Mitochondrion.

[27]  E. Bertini,et al.  Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases. , 2009, Biochimica et biophysica acta.

[28]  A. Falcão,et al.  Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. , 2009, Molecular nutrition & food research.

[29]  L. A. Obukhova,et al.  An attempt to prevent senescence: a mitochondrial approach. , 2009, Biochimica et biophysica acta.

[30]  J. Smeitink,et al.  The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency , 2009, Journal of Molecular Medicine.

[31]  A. Suomalainen,et al.  Mouse models of mitochondrial DNA defects and their relevance for human disease , 2009, EMBO reports.

[32]  R. Rodenburg,et al.  Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. , 2008, Brain : a journal of neurology.

[33]  G. Paradies,et al.  Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin. , 2009, Free radical biology & medicine.

[34]  M. Hink,et al.  Chapter 16 The use of fluorescence correlation spectroscopy to probe mitochondrial mobility and intramatrix protein diffusion. , 2009, Methods in enzymology.

[35]  Rutger O. Vogel,et al.  Subunits of Mitochondrial Complex I Exist as Part of Matrix- and Membrane-associated Subcomplexes in Living Cells* , 2008, Journal of Biological Chemistry.

[36]  A. Torraco,et al.  Mouse models of oxidative phosphorylation dysfunction and disease. , 2008, Methods.

[37]  V. Skulachev,et al.  Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and Age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke) , 2008, Biochemistry (Moscow).

[38]  N. Wood,et al.  Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts , 2008, Annals of neurology.

[39]  B. Spiegelman,et al.  Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. , 2008, Cell metabolism.

[40]  A. Bonen,et al.  PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[41]  J. Brotchie,et al.  Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. , 2008, Biochemical and biophysical research communications.

[42]  J. Smeitink,et al.  Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. , 2008, Biochimica et biophysica acta.

[43]  J. Smeitink,et al.  Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency. , 2008, Cell calcium.

[44]  J. Fransen,et al.  Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. , 2008, American journal of physiology. Cell physiology.

[45]  F. Daussin,et al.  Training at high exercise intensity promotes qualitative adaptations of mitochondrial function in human skeletal muscle. , 2008, Journal of applied physiology.

[46]  Robin A. J. Smith,et al.  Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. , 2008, The Biochemical journal.

[47]  R. Houtkooper,et al.  Cardiolipin, the heart of mitochondrial metabolism , 2008, Cellular and Molecular Life Sciences.

[48]  W. Watt,et al.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.

[49]  A. Munnich,et al.  Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. , 2008, The Journal of clinical endocrinology and metabolism.

[50]  R. Scarpulla.  Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.

[51]  J. Smeitink,et al.  Life cell quantification of mitochondrial membrane potential at the single organelle level , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[52]  H. Szeto.  Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents , 2006, The AAPS Journal.

[53]  J. Smeitink,et al.  Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. , 2007, Biochimica et biophysica acta.

[54]  I. Tucker,et al.  Quantitation and metabolism of mitoquinone, a mitochondria-targeted antioxidant, in rat by liquid chromatography/tandem mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[55]  J. Smeitink,et al.  Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. , 2007, Biochimica et biophysica acta.

[56]  J. Smeitink,et al.  Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? , 2007, American journal of physiology. Cell physiology.

[57]  Massimo Zeviani,et al.  Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. , 2007, Human molecular genetics.

[58]  M. Lazarou,et al.  Analysis of the Assembly Profiles for Mitochondrial- and Nuclear-DNA-Encoded Subunits into Complex I , 2007, Molecular and Cellular Biology.

[59]  Rutger O. Vogel,et al.  Identification of Mitochondrial Complex I Assembly Intermediates by Tracing Tagged NDUFS3 Demonstrates the Entry Point of Mitochondrial Subunits* , 2007, Journal of Biological Chemistry.

[60]  Christian Gluud,et al.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. , 2007, JAMA.

[61]  Robin A. J. Smith,et al.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations. , 2007, Annual review of pharmacology and toxicology.

[62]  C. Pinkert,et al.  Generation of transmitochondrial mice: development of xenomitochondrial mice to model neurodegenerative diseases. , 2007, Methods in cell biology.

[63]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[64]  J. Smeitink,et al.  Simultaneous quantification of oxidative stress and cell spreading using 5‐(and‐6)‐chloromethyl‐2′,7′‐dichlorofluorescein , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[65]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[66]  Ulrich Brandt,et al.  Energy converting NADH:quinone oxidoreductase (complex I). , 2006, Annual review of biochemistry.

[67]  M. Sharpley,et al.  Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria. , 2006, Biochemistry.

[68]  A. Leusink,et al.  Decreased agonist-stimulated mitochondrial ATP production caused by a pathological reduction in endoplasmic reticulum calcium content in human complex I deficiency. , 2006, Biochimica et biophysica acta.

[69]  Werner J H Koopman,et al.  Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[70]  H. Szeto,et al.  Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. , 2005, Biochemical pharmacology.

[71]  R. Haller,et al.  Exercise and training in mitochondrial myopathies. , 2005, Medicine and science in sports and exercise.

[72]  A. Navarro,et al.  Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[73]  E. Shoubridge,et al.  A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. , 2005, The Journal of clinical investigation.

[74]  J. Smeitink,et al.  Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. , 2005, American journal of physiology. Cell physiology.

[75]  D. Chan,et al.  Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction* , 2005, Journal of Biological Chemistry.

[76]  F. H. van der Westhuizen,et al.  Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. , 2005, American journal of physiology. Cell physiology.

[77]  K. Kraemer,et al.  Vitamins E and C are safe across a broad range of intakes. , 2005, The American journal of clinical nutrition.

[78]  D. Kelly,et al.  Mouse models of mitochondrial dysfunction and heart failure. , 2005, Journal of molecular and cellular cardiology.

[79]  R. Haller,et al.  Implications of exercise training in mtDNA defects--use it or lose it? , 2004, Biochimica et biophysica acta.

[80]  G. Rutter,et al.  Inhibition of Mitochondrial Na (cid:1) -Ca 2 (cid:1) Exchange Restores Agonist-induced ATP Production and Ca 2 (cid:1) Handling in Human Complex I Deficiency* , 2004 .

[81]  H. Szeto,et al.  Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury* , 2004, Journal of Biological Chemistry.

[82]  A. Boneh,et al.  Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases , 2004, Journal of Inherited Metabolic Disease.

[83]  E. Ojuka.  Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle , 2004, The Proceedings of the Nutrition Society.

[84]  C. Bruno,et al.  Respiratory complex III is required to maintain complex I in mammalian mitochondria. , 2004, Molecular cell.

[85]  J. Smeitink,et al.  Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. , 2004, Human molecular genetics.

[86]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[87]  D. Glerum,et al.  Nutritional cofactor treatment in mitochondrial disorders. , 2003, Journal of the American Dietetic Association.

[88]  R. Bassel-Duby,et al.  Regulation of Mitochondrial Biogenesis in Skeletal Muscle by CaMK , 2002, Science.

[89]  O. Elpeleg,et al.  Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency. , 2001, The Journal of pediatrics.

[90]  I. Nissim,et al.  Brain amino acid metabolism and ketosis , 2001, Journal of neuroscience research.

[91]  B. Cohen,et al.  Treatment of Mitochondrial Cytopathies , 2001, Seminars in neurology.

[92]  P. Mongan,et al.  Ascorbate reduces superoxide production and improves mitochondrial respiratory chain function in human fibroblasts with electron transport chain deficiencies. , 2001, Mitochondrion.

[93]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[94]  M. L. Greenberg,et al.  The biosynthesis and functional role of cardiolipin. , 2000, Progress in lipid research.

[95]  C. Angelini,et al.  Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. , 1999, Brain : a journal of neurology.

[96]  E. Schon,et al.  A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency , 1999, Nature Medicine.

[97]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[98]  S. Combs,et al.  Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. , 1994, The Journal of investigative dermatology.

[99]  P. Bergsten,et al.  Ascorbic acid accumulation and transport in human fibroblasts. , 1993, The Biochemical journal.

[100]  M. A. Matlib,et al.  A role for the mitochondrial Na(+)-Ca2+ exchanger in the regulation of oxidative phosphorylation in isolated heart mitochondria. , 1993, The Journal of biological chemistry.

[101]  E. Niki,et al.  Action of ascorbic acid as a scavenger of active and stable oxygen radicals. , 1991, The American journal of clinical nutrition.